Result: Prostate-specific antigen nadir and cancer-control ouutcomes in real-world apalutamide-treated metastatic hormone-sensitive prostate cancer patients: a single-center analysis

*Title*:

*Author/editor-in-chief*:

*Published in*:

European urology oncology. - Amsterdam : Elsevier, 31.08.2024. - Seite 364-371. - 10.1016/j.euo.2024.08.007. - ISSN 2588-9311. - Jahrgang 8, Heft 2

*Publication*:

Amsterdam : Elsevier, 31.08.2024

*Distribution*:

Frankfurt am Main : Universitätsbibliothek Johann Christian Senckenberg

*Physical description scale*:

1 Online-Ressource (8 Seiten)

*Format*:

*eBook*

*Language*:

*eng*

*DOI*:

10.1016/j.euo.2024.08.007

*oa_rights*:

Open Access
CC BY-NC-ND 4.0

*Result*: Prostate-specific antigen nadir and cancer-control ouutcomes in real-world apalutamide-treated metastatic hormone-sensitive prostate cancer patients: a single-center analysis